Sustained elevation of serum interleukin-6 and relative insensitivity to hydrocortisone differentiates posttraumatic stress disorder with and without depression

Biological Psychiatry

Volumn 68, Issue 11, 2010, Pages 999-1006

  Gill, Jessica ^a   Luckenbaugh, David ^a   Charney, Dennis ^b   Vythilingam, Meena ^a,c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c Office of the Assistant Secretary of Defense   (United States)

Author keywords

Depression; Glucocorticoid sensitivity; Hydrocortisone; PTSD; Serial sampling; Serum IL 6

Indexed keywords

CORTICOTROPIN; FLUOXETINE; HYDROCORTISONE; INTERLEUKIN 6;

ADULT; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS;

ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; AREA UNDER CURVE; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYDROCORTISONE; INTERLEUKIN-6; MALE; MIDDLE AGED; STRESS DISORDERS, POST-TRAUMATIC;

EID: 78349312880     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2010.07.033     Document Type: Article

References (77)

1. R. Kimerling An investigation of sex differences in nonpsychiatric morbidity associated with posttraumatic stress disorder J Am Med Womens Assoc 59 2004 43 47
2. J.L. Kibler Posttraumatic stress and cardiovascular disease risk J Trauma Dissociation 10 2009 135 150
3. J.A. Boscarino External-cause mortality after psychologic trauma: The effects of stress exposure and predisposition Compr Psychiatry 47 2006 503 514
4. J.A. Boscarino A prospective study of PTSD and early-age heart disease mortality among Vietnam veterans: Implications for surveillance and prevention Psychosom Med 70 2008 668 676
5. M. Jakovljevic, D. Babic, Z. Crncevic, M. Martinac, B. Maslov, and R. Topic Metabolic syndrome and depression in war veterans with post-traumatic stress disorder Psychiatr Danub 20 2008 406 410
6. P.S. Heppner, E.F. Crawford, U.A. Haji, N. Afari, R.L. Hauger, and B.A. Dashevsky The association of posttraumatic stress disorder and metabolic syndrome: A study of increased health risk in veterans BMC Med 7 2009 1
7. M.D. Marciniak, M.J. Lage, E. Dunayevich, J.M. Russell, L. Bowman, R.P. Landbloom, and L.R. Levine The cost of treating anxiety: The medical and demographic correlates that impact total medical costs Depress Anxiety 21 2005 178 184
8. S.A. Rauch, K.H. Morales, C. Zubritsky, K. Knott, and D. Oslin Posttraumatic stress, depression, and health among older adults in primary care Am J Geriatr Psychiatry 14 2006 316 324
9. G.A. Clum, K.S. Calhoun, and R. Kimerling Associations among symptoms of depression and posttraumatic stress disorder and self-reported health in sexually assaulted women J Nerv Ment Dis 188 2000 671 678
10. T. Tanielian, and L. Jaycox Invisible Wounds of War: Psychological and Cognitive Injuries, Their Consequences, and Services to Assist Recovery 2008 RAND Corporation Santa Monica, CA
11. C. Janeway Immunobiology 2005 Garland Science Publishing New York
12. K. Andersen, and B.K. Pedersen The role of inflammation in vascular insulin resistance with focus on IL-6 Horm Metab Res 40 2008 635 639
13. N. Gokce, J.F. Keaney Jr, L.M. Hunter, M.T. Watkins, J.O. Menzoian, and J.A. Vita Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: A prospective study Circulation 105 2002 1567 1572
14. M. Jacobs, M.M. van Greevenbroek, C.J. van der Kallen, I. Ferreira, E.E. Blaak, and E.J. Feskens Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: The CODAM study Eur J Clin Invest 39 2009 437 444
15. M. Maes, A.H. Lin, L. Delmeire, A. Van Gastel, G. Kenis, R. De Jongh, and E. Bosmans Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events Biol Psychiatry 45 1999 833 839
16. J. Gill, M. Vythilingam, and G.G. Page Low cortisol, high DHEA, and high levels of stimulated TNF-alpha, and IL-6 in women with PTSD J Trauma Stress 21 2008 530 539
17. N. Rohleder, L. Joksimovic, J.M. Wolf, and C. Kirschbaum Hypocortisolism and increased glucocorticoid sensitivity of pro-inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder Biol Psychiatry 55 2004 745 751
18. D.G. Baker, N.N. Ekhator, J.W. Kasckow, K.K. Hill, E. Zoumakis, and B.A. Dashevsky Plasma and cerebrospinal fluid interleukin-6 concentrations in posttraumatic stress disorder Neuroimmunomodulation 9 2001 209 217
19. R. von Kanel, S. Begre, C.C. Abbas, H. Saner, M.L. Gander, and J.P. Schmid Inflammatory biomarkers in patients with posttraumatic stress disorder caused by myocardial infarction and the role of depressive symptoms Neuroimmunomodulation 17 2010 39 46
20. R.J. Miller, A.G. Sutherland, J.D. Hutchison, and D.A. Alexander C-reactive protein and interleukin 6 receptor in post-traumatic stress disorder: A pilot study Cytokine 13 2001 253 255
21. R. von Kanel, U. Hepp, B. Kraemer, R. Traber, M. Keel, L. Mica, and U. Schnyder Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder J Psychiatr Res 41 2007 744 752
22. P. Pervanidou, G. Kolaitis, S. Charitaki, A. Margeli, S. Ferentinos, and C. Bakoula Elevated morning serum interleukin (IL)-6 or evening salivary cortisol concentrations predict posttraumatic stress disorder in children and adolescents six months after a motor vehicle accident Psychoneuroendocrinology 32 2007 991 999
23. Y. Song, D. Zhou, and X. Wang Increased serum cortisol and growth hormone levels in earthquake survivors with PTSD or subclinical PTSD Psychoneuroendocrinology 33 2008 1155 1159
24. A.N. Vgontzas, E.O. Bixler, H.M. Lin, P. Prolo, G. Trakada, and G.P. Chrousos IL-6 and its circadian secretion in humans Neuroimmunomodulation 12 2005 131 140
25. E. Fries, J. Hesse, J. Hellhammer, and D.H. Hellhammer A new view on hypocortisolism Psychoneuroendocrinology 30 2005 1010 1016
26. S.R. Kunz-Ebrecht, V. Mohamed-Ali, P.J. Feldman, C. Kirschbaum, and A. Steptoe Cortisol responses to mild psychological stress are inversely associated with proinflammatory cytokines Brain Behav Immun 17 2003 373 383
27. C.L. Raison, and A.H. Miller When not enough is too much: The role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders Am J Psychiatry 160 2003 1554 1565
28. E.D. Kanter, C.W. Wilkinson, A.D. Radant, E.C. Petrie, D.J. Dobie, and M.E. McFall Glucocorticoid feedback sensitivity and adrenocortical responsiveness in posttraumatic stress disorder Biol Psychiatry 50 2001 238 245
29. M. Vythilingam, J.M. Gill, D.A. Luckenbaugh, P.W. Gold, C. Collin, and O. Bonne Low early morning plasma cortisol in posttraumatic stress disorder is associated with co-morbid depression but not with enhanced glucocorticoid feedback inhibition Psychoneuroendocrinology 35 2010 442 450
30. M.A. Oquendo, G. Echavarria, H.C. Galfalvy, M.F. Grunebaum, A. Burke, and A. Barrera Lower cortisol levels in depressed patients with comorbid post-traumatic stress disorder Neuropsychopharmacology 28 2003 591 598
31. C.S. de Kloet, E. Vermetten, C.J. Heijnen, E. Geuze, E.G. Lentjes, and H.G. Westenberg Enhanced cortisol suppression in response to dexamethasone administration in traumatized veterans with and without posttraumatic stress disorder Psychoneuroendocrinology 32 2007 215 226
32. H.H. Wang, Z.J. Zhang, Q.R. Tan, H. Yin, Y.C. Chen, and H.N. Wang Psychopathological, biological, and neuroimaging characterization of posttraumatic stress disorder in survivors of a severe coalmining disaster in China J Psychiatr Res 44 2010 385 392
33. R. Yehuda, D. Boisoneau, M.T. Lowy, and E.L. Giller Jr Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder Arch Gen Psychiatry 52 1995 583 593
34. A.K. Goenjian, R. Yehuda, R.S. Pynoos, A.M. Steinberg, M. Tashjian, and R.K. Yang Basal cortisol, dexamethasone suppression of cortisol, and MHPG in adolescents after the 1988 earthquake in Armenia Am J Psychiatry 153 1996 929 934
35. R. Yehuda, J.A. Golier, S.L. Halligan, M. Meaney, and L.M. Bierer The ACTH response to dexamethasone in PTSD Am J Psychiatry 161 2004 1397 1403
36. M.G. Griffin, P.A. Resick, and R. Yehuda Enhanced cortisol suppression following dexamethasone administration in domestic violence survivors Am J Psychiatry 162 2005 1192 1199
37. J.A. Golier, J. Schmeidler, J. Legge, and R. Yehuda Enhanced cortisol suppression to dexamethasone associated with Gulf War deployment Psychoneuroendocrinology 31 2006 1181 1189
38. C. Otte, M. Lenoci, T. Metzler, R. Yehuda, C.R. Marmar, and T.C. Neylan Hypothalamic-pituitary-adrenal axis activity and sleep in posttraumatic stress disorder Neuropsychopharmacology 30 2005 1173 1180
39. D.S. Lipschitz, A.M. Rasmusson, R. Yehuda, S. Wang, W. Anyan, and R. Gueoguieva Salivary cortisol responses to dexamethasone in adolescents with posttraumatic stress disorder J Am Acad Child Adolesc Psychiatry 42 2003 1310 1317 (Pubitemid 39585991)
40. S.E. Lindley, E.B. Carlson, and M. Benoit Basal and dexamethasone suppressed salivary cortisol concentrations in a community sample of patients with posttraumatic stress disorder Biol Psychiatry 55 2004 940 945
41. C. de Kloet, E. Vermetten, E. Lentjes, E. Geuze, J. van Pelt, and R. Manuel Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder Psychoneuroendocrinology 33 2008 313 320
42. A. Strohle, M. Scheel, S. Modell, and F. Holsboer Blunted ACTH response to dexamethasone suppression-CRH stimulation in posttraumatic stress disorder J Psychiatr Res 42 2008 1185 1188
43. M.A. Cole, P.J. Kim, B.A. Kalman, and R.L. Spencer Dexamethasone suppression of corticosteroid secretion: Evaluation of the site of action by receptor measures and functional studies Psychoneuroendocrinology 25 2000 151 167
44. R. Yehuda, R.K. Yang, M.S. Buchsbaum, and J.A. Golier Alterations in cortisol negative feedback inhibition as examined using the ACTH response to cortisol administration in PTSD Psychoneuroendocrinology 31 2006 447 451
45. M.J. Gray, B.T. Litz, J.L. Hsu, and T.W. Lombardo Psychometric properties of the life events checklist Assessment 11 2004 330 341
46. M.B. First, R.L. Spitzer, M. Gibbon, and J.B.W. Williams Structured Clinical Interview for DSM-IV-TR Axis I Disorders 2001 Biometrics Research Department, New York State Psychiatric Institute New York
47. A.J. Rush, C.M. Gullion, M.R. Basco, R.B. Jarrett, and M.H. Trivedi The Inventory of Depressive Symptomatology (IDS): Psychometric properties Psychol Med 26 1996 477 486
48. E. Lichtenberger, and A. Kaufman Assessing Adolescent and Adult Intelligence 2003 Allyn &. Bacon Boston
49. S. Alesci, P.E. Martinez, S. Kelkar, I. Ilias, D.S. Ronsaville, and S.J. Listwak Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: Clinical implications J Clin Endocrinol Metab 90 2005 2522 2530
50. P. Bob, J. Raboch, M. Maes, M. Susta, J. Pavlat, and D. Jasova Depression, traumatic stress and interleukin-6 J Affect Disord 120 2010 231 234
51. M. Vythilingam, C. Heim, J. Newport, A.H. Miller, E. Anderson, and R. Bronen Childhood trauma associated with smaller hippocampal volume in women with major depression Am J Psychiatry 159 2002 2072 2080
52. S. Zalcman, J.M. Green-Johnson, L. Murray, D.M. Nance, D. Dyck, H. Anisman, and A.H. Greenberg Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6 Brain Res 643 1994 40 49
53. W.J. Kop, N.J. Weissman, J. Zhu, R.W. Bonsall, M. Doyle, and M.R. Stretch Effects of acute mental stress and exercise on inflammatory markers in patients with coronary artery disease and healthy controls Am J Cardiol 101 2008 767 773
54. H. Anisman Cascading effects of stressors and inflammatory immune system activation: Implications for major depressive disorder J Psychiatry Neurosci 34 2009 4 20
55. D.A. Papanicolaou, R.L. Wilder, S.C. Manolagas, and G.P. Chrousos The pathophysiologic roles of interleukin-6 in human disease Ann Intern Med 128 1998 127 137
56. U. Vollmer-Conna, C. Fazou, B. Cameron, H. Li, C. Brennan, and L. Luck Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans Psychol Med 34 2004 1289 1297
57. M. Maes, L. Capuron, A. Ravaud, N. Gualde, E. Bosmans, and B. Egyed Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy Neuropsychopharmacology 24 2001 130 140
58. L. Capuron, A. Ravaud, A.H. Miller, and R. Dantzer Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy Brain Behav Immun 18 2004 205 213
59. M. Maes, S. Bonaccorso, V. Marino, A. Puzella, M. Pasquini, and M. Biondi Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation Mol Psychiatry 6 2001 475 480
60. S. Beratis, A. Katrivanou, S. Georgiou, A. Monastirli, E. Pasmatzi, P. Gourzis, and D. Tsambaos Major depression and risk of depressive symptomatology associated with short-term and low-dose interferon-alpha treatment J Psychosom Res 58 2005 15 18
61. M.C. Wichers, G. Kenis, G.H. Koek, G. Robaeys, N.A. Nicolson, and M. Maes Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol J Psychosom Res 62 2007 207 214
62. L.M. Harden, I. du Plessis, S. Poole, and H.P. Laburn Interleukin-6 and leptin mediate lipopolysaccharide-induced fever and sickness behavior Physiol Behav 89 2006 146 155
63. B. Sakic, H. Szechtman, T. Braciak, C. Richards, J. Gauldie, and J.A. Denburg Reduced preference for sucrose in autoimmune mice: A possible role of interleukin-6 Brain Res Bull 44 1997 155 165
64. B. Sakic, J. Gauldie, J.A. Denburg, and H. Szechtman Behavioral effects of infection with IL-6 adenovector Brain Behav Immun 15 2001 25 42
65. S. Tyring, A. Gottlieb, K. Papp, K. Gordon, C. Leonardi, and A. Wang Etanercept and clinical outcomes, fatigue, and depression in psoriasis: Double-blind placebo-controlled randomised phase III trial Lancet 367 2006 29 35
66. N. Muller, M.J. Schwarz, S. Dehning, A. Douhe, A. Cerovecki, and B. Goldstein-Muller The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: Results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine Mol Psychiatry 11 2006 680 684
67. A. Aerni, R. Traber, C. Hock, B. Roozendaal, G. Schelling, and A. Papassotiropoulos Low-dose cortisol for symptoms of posttraumatic stress disorder Am J Psychiatry 161 2004 1488 1490 (Pubitemid 38989105)
68. F. Weis, E. Kilger, B. Roozendaal, D.J. de Quervain, P. Lamm, and M. Schmidt Stress doses of hydrocortisone reduce chronic stress symptoms and improve health-related quality of life in high-risk patients after cardiac surgery: A randomized study J Thorac Cardiovasc Surg 131 2006 277 282
69. G. Schelling, B. Roozendaal, T. Krauseneck, M. Schmoelz, D. DE Quervain, and J. Briegel Efficacy of hydrocortisone in preventing posttraumatic stress disorder following critical illness and major surgery Ann N Y Acad Sci 1071 2006 46 53
70. R.H. Pietrzak, A. Fredrickson, P.J. Snyder, and P. Maruff A comparison of statistical approaches used to evaluate change in cognitive function following pharmacologic challenge: An example with lorazepam Hum Psychopharmacol 25 2010 335 341
71. M. Uddin, A.E. Aiello, D.E. Wildman, K.C. Koenen, G. Pawelec, and R. de los Santos Epigenetic and immune function profiles associated with posttraumatic stress disorder Proc Natl Acad Sci U S A 107 2010 9470 9475
72. P. Woo, N. Wilkinson, A.M. Prieur, T. Southwood, V. Leone, and P. Livermore Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: Proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement Arthritis Res Ther 7 2005 R1281 R1288
73. M.S. Angst, J.D. Clark, B. Carvalho, M. Tingle, M. Schmelz, and D.C. Yeomans Cytokine profile in human skin in response to experimental inflammation, noxious stimulation, and administration of a COX-inhibitor: A microdialysis study Pain 139 2008 15 27
74. T.W. Pace, L.T. Negi, D.D. Adame, S.P. Cole, T.I. Sivilli, and T.D. Brown Effect of compassion meditation on neuroendocrine, innate immune and behavioral responses to psychosocial stress Psychoneuroendocrinology 34 2009 87 98
75. W.J. Elliot Cyclic and circadian variations in cardiovascular events Am J Hypertens 14 2001 291S 295S
76. S.N. Willich, R.J. Goldberg, M. Maclure, L. Perriello, and J.E. Muller Increased onset of sudden cardiac death in the first three hours after awakening Am J Cardiol 70 1992 65 68
77. A. Dominguez-Rodriguez, P. Abreu-Gonzalez, M. Garcia, J. Ferrer, A. de la Rosa, M. Vargas, and R.J. Reiter Light/dark patterns of interleukin-6 in relation to the pineal hormone melatonin in patients with acute myocardial infarction Cytokine 26 2004 89 93